News for 'prescriptions'

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Deadly cough syrup toll rises to 20 in MP; Kerala bans Sresan medicines

Rediff.com8 Oct 2025

Madhya Pradesh Deputy Chief Minister Rajendra Shukla confirmed that 20 children have died after consuming contaminated cough syrup. An investigation is underway, and action has been taken against the manufacturer, doctor, and FDA officials.

Bindra report exposes flaws in India's sports administration

Bindra report exposes flaws in India's sports administration

Rediff.com30 Dec 2025

'Neither SAI nor state departments have a dedicated sports administration service. Instead, roles are filled by generalist civil servants or contractual staff, often lacking sector-specific expertise.'

Microsoft to invest $17.5 billion for India's AI-first future: Nadella

Microsoft to invest $17.5 billion for India's AI-first future: Nadella

Rediff.com9 Dec 2025

Microsoft CEO Satya Nadella on Tuesday announced plans to invest $17.5 billion in India to help build infrastructure and sovereign capabilities for the country's AI-first future, marking the third major AI-driven investment in the country in the past two months. Microsoft said that the $17.5 billion (around Rs 1.58 lakh crore) investment builds on the $3 billion (around Rs 26,955 crore) funding announced earlier this year, which the company is on track to spend by the end of CY (calendar year) 2026.

Lenskart to launch IPO on Oct 31; aims to raise Rs 2,150-cr

Lenskart to launch IPO on Oct 31; aims to raise Rs 2,150-cr

Rediff.com26 Oct 2025

Eyewear retailer Lenskart Solutions is gearing up to launch its initial public offering (IPO) on October 31, aiming to raise Rs 2,150 crore through a fresh issue of shares. This marks its much-awaited entry into the public markets.

Why IT Firms Face 5-10% Payroll Hike

Why IT Firms Face 5-10% Payroll Hike

Rediff.com24 Nov 2025

'Companies will need to revisit compensation structures, contracts, staffing models, and human resources system.'

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Govt moots power sector reforms to address discom losses

Govt moots power sector reforms to address discom losses

Rediff.com15 Oct 2025

The idea is to establish a robust and forward-looking legal framework that addresses the financial stress of power distribution companies, which are facing losses of over 6.9 trillion, while curbing high industrial tariffs that, according to the government, have affected competitiveness, constrained economic growth, and slowed the transition to clean energy.

Can MFN Pricing Reshape India-US Pharma Equation?

Can MFN Pricing Reshape India-US Pharma Equation?

Rediff.com5 Jun 2025

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).

M&A financing the new frontier for banks, but RBI's watching

M&A financing the new frontier for banks, but RBI's watching

Rediff.com26 Nov 2025

Mint Road's proposals on banks' M&A funding are cautious even as entrants root for more elbow room, and weigh business models.

Lenskart eyeing mega expansion as it readies for IPO

Lenskart eyeing mega expansion as it readies for IPO

Rediff.com15 Oct 2025

Eyewear retailer Lenskart plans to add 450 stores in the current financial year, its fastest expansion in three years, as the company prepares for a public listing that could value it at up to $10 billion. The addition would take Lenskart's store count to more than 3,150 across 14 countries, representing a 34 per cent rise from the 334 stores opened last year.

4 Reasons To Buy THIS Illness Insurance

4 Reasons To Buy THIS Illness Insurance

Rediff.com6 Oct 2025

When illness strikes, this cover cushions the fall -- guarding health, finances, and the family's fragile future

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Anupam Mittal's Dhandha Mantra For Start-Up Success

Anupam Mittal's Dhandha Mantra For Start-Up Success

Rediff.com23 Oct 2025

'First, develop the ability to sell -- to persuade, negotiate and close. Second, understand the financial mechanics that determine where value pools and how profits are captured,' says Shaadi.com founder Anupam Mittal.

How To Deal with Medical Negligence

How To Deal with Medical Negligence

Rediff.com10 Oct 2025

Medical negligence arises when a medical professional deviates from reasonable standards of care, causing injury to the patient.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

Is this medicine harmful during pregnancy? Trump links it to autism

Is this medicine harmful during pregnancy? Trump links it to autism

Rediff.com23 Sep 2025

In contrast to Trump's strong warnings, the FDA's current position remains more measured. In a recent letter to physicians, the agency stated that "a causal relationship has not been established" between acetaminophen use during pregnancy and autism, and acknowledged the existence of "contrary studies in the scientific literature."

Will Japan's Iron Lady Deepen India-Japan Ties?

Will Japan's Iron Lady Deepen India-Japan Ties?

Rediff.com15 Oct 2025

As a protege of Shinzo Abe, Takaichi is expected to scale bilateral ties much higher. Trade and investment shall grow. People-to-people contacts shall be scaled up, points out Dr Rajaram Panda.

IIM-Calcutta rape case: Accused used sleeping pills to spike cold drinks

IIM-Calcutta rape case: Accused used sleeping pills to spike cold drinks

Rediff.com14 Jul 2025

Police, however, have found several discrepancies in the statements of the accused student of the IIM-Calcutta, he said.

Alert! Why 120/80 BP Is Now High Risk

Alert! Why 120/80 BP Is Now High Risk

Rediff.com26 Aug 2025

Blood pressure management is no longer just about a number on a chart

Prescription drugs still available online

Prescription drugs still available online

Rediff.com4 May 2015

The FDA Maharashtra on Friday lodged an FIR against Snapdeal.

Prescription not needed for Covid test in Mumbai now

Prescription not needed for Covid test in Mumbai now

Rediff.com7 Jul 2020

The civic body also informed that those kept in institutional quarantine will be discharged only when they test negative for the virus. Municipal commissioner Iqbal Singh Chahal took the decision to allow testing without medical prescription in view of increase in the number of private laboratories and their capacity, it said in a release.

'Trump Is Frustrated'

'Trump Is Frustrated'

Rediff.com4 Aug 2025

'What India has done will surely embolden more countries to stand up to Trump.'

Prescriptions a must to buy ayurveda drugs online, says consumer body

Prescriptions a must to buy ayurveda drugs online, says consumer body

Rediff.com14 Jul 2022

The Central Consumer Protection Authority (CCPA) on Thursday directed e-commerce entities to sell specified ayurveda, siddha and unani drugs only after customers upload valid medical prescriptions from registered doctors on the platforms.

Wockhardt exits US generics biz, to focus on innovation

Wockhardt exits US generics biz, to focus on innovation

Rediff.com12 Jul 2025

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.

Khemka Murder: Shooter's Wife Refutes Police

Khemka Murder: Shooter's Wife Refutes Police

Rediff.com13 Jul 2025

'My husband weighs 102 kg, has a steel rod in his leg, how can he flee like the shooter in the CCTV footage?'

Shortcuts Won't Build Industrial Capability

Shortcuts Won't Build Industrial Capability

Rediff.com28 Jul 2025

Any industrial policy is only as good as how it is applied and the other reforms that support it. This was as true 40 years ago as it is now, points out Debashis Basu.

Should CJI be involved in executive appointments? Experts differ

Should CJI be involved in executive appointments? Experts differ

Rediff.com15 Feb 2025

The views came in the wake of Vice President Jagdeep Dhankhar wondering on Friday that how could the CJI, even by "statutory prescription", get involved in executive appointments such as that of Central Bureau of Investigation director, and said it was time to "revisit" such norms.

You may not get even cold meds without prescription

You may not get even cold meds without prescription

Rediff.com1 May 2020

Although there is no government order to this effect, chemists decide to not dispense medicines for cold, cough and fever over the counter.

Case of wrong diagnosis and prescription: Cong on Budget

Case of wrong diagnosis and prescription: Cong on Budget

Rediff.com1 Feb 2021

The Congress on Monday strongly criticised the Union budget, saying Finance Minister Nirmala Sitharaman's speech was oblivious to the declining GDP and the budget was a case of "wrong diagnosis and prescription".

Trump's drug price cut plan may put pressure on India

Trump's drug price cut plan may put pressure on India

Rediff.com12 May 2025

US President Donald Trump's plan to sign an executive order to cut prescription drug prices by 30-80 per cent could lead to a global price adjustment with pharma firms pushing lower-cost countries like India to raise prices, according to the economic think tank GTRI. The US move could push prices in lower-cost countries like India as manufacturers would seek to recover losses and R&D costs from these nations.

Memes Galore After Budget

Memes Galore After Budget

Rediff.com1 Feb 2025

Netizens broke out into a meme fest as they welcomed Nirmala Sitharaman's tax break.

Time to revisit CJI's role in executive appointments: Dhankhar

Time to revisit CJI's role in executive appointments: Dhankhar

Rediff.com14 Feb 2025

Vice President Jagdeep Dhankhar has questioned the Chief Justice of India's involvement in executive appointments, specifically citing the selection of the CBI director. He believes this practice undermines democratic principles and calls for revisiting the existing norms. Dhankhar also raised concerns about the "doctrine of basic structure", suggesting it has a debatable jurisprudential basis. He emphasized the importance of each institution operating within its constitutional boundaries and highlighted the need for coordinated autonomy. The vice president also discussed the need for a balanced approach to judicial review and the importance of judges focusing on judgments rather than other forms of expression. He stressed the need to revisit the current state of affairs to restore the judiciary's sublimity.

Maharashtra asks Snapdeal to stop selling prescription drugs

Maharashtra asks Snapdeal to stop selling prescription drugs

Rediff.com18 Apr 2015

Flipkart, Amazon, too, under radar

India-Pak clash is about terrorism, West will suffer too: Jaishankar

India-Pak clash is about terrorism, West will suffer too: Jaishankar

Rediff.com11 Jun 2025

External Affairs Minister S Jaishankar has said the recent confrontation between India and Pakistan was not just a mere conflict between two neighbours, but it was about combating terrorism, which will eventually come back to haunt the West.

Mounjaro, weight-loss, type 2 diabetes drug, launched in India

Mounjaro, weight-loss, type 2 diabetes drug, launched in India

Rediff.com20 Mar 2025

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

Prescription drugs: The ticking time bomb

Prescription drugs: The ticking time bomb

Rediff.com2 Jul 2009

The sudden demise of King of Pop Michael Jackson has reopened a can of worms.

Where is Papa?: Pahalgam victim's child inconsolable

"Where is Papa?": Pahalgam victim's child inconsolable

Rediff.com24 Apr 2025

Each time her little boy wakes up from sleep, his voice trembles with the same haunting questions: "Where is Papa? Did he go somewhere?"

'Jacko had problems with prescription drugs'

'Jacko had problems with prescription drugs'

Rediff.com26 Jun 2009

Brian Oxman, who says that he has been the family's attorney for 20-years, though he disassociated himself from the defence team in 2005 during Jackson's molestation case, said that he had warned the singer's family members about the drug usage.